REFERENCES
1. Cao F, Guo N, Yuan Z. Reports from the 2021 Great Wall International Congress of Cardiology in China. Eur Heart J 2021:ehab852.
2. Anker SD, Butler J, Khan MS, et al. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J 2020;41:2109-17.
3. Bakris G, Ali W, Parati G. ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison. J Am Coll Cardiol 2019;73:3018-26.
4. Han Y, Zeng H, Jiang H, et al. CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic. Circulation 2020;141:e810-6.
5. Gao R. CIT 2018: A New Era, New Journey: Report from the China Interventional Therapeutics (CIT) 2018, the largest interventional cardiology scientific congress in the Asia-Pacific region. Eur Heart J 2018;39:2515-7.
6. Hohenschurz-Schmidt D, Vase L, Scott W, et al. Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the CoPPS Statement. BMJ 2023;381:e072108.
7. Gheorghiade M, Larson CJ, Shah SJ, et al. Developing New Treatments for Heart Failure: Focus on the Heart. Circ Heart Fail 2016;9:e002727.
8. Cottler LB, Nagarajan R. Real-time assessment of community health needs and concerns. Sci Transl Med 2012;4:119mr2.
9. Anderson JE, Aase K, Bal R, et al. Multilevel influences on resilient healthcare in six countries: an international comparative study protocol. BMJ Open 2020;10:e039158.
10. Holmes C, McDonald F, Jones M, Graham J. Knowledge Translation: Moving Proteomics Science to Innovation in Society. OMICS 2016;20:352-61.
11. Ortmann O, Torode J, Harrison C, Bruns J, Helbig U; Participants of the ERTM. Research driving innovation: what are key factors for successful integration of translational science into oncology care concepts? 5th European Roundtable Meeting (ERTM) May 4th, 2018, Berlin, Germany. J Cancer Res Clin Oncol 2019;145:1521-5.
12. Khan SS, Post WS, Guo X, et al. Coronary Artery Calcium Score and Polygenic Risk Score for the Prediction of Coronary Heart Disease Events. JAMA 2023;329:1768-77.
13. Stähli BE, Varbella F, Linke A, et al. MULTISTARS AMI Investigators. Timing of Complete Revascularization with Multivessel PCI for Myocardial Infarction. N Engl J Med 2023;389:1368-79.
14. Writing Committee for the REMAP-CAP Investigators; Lawler PR, Derde LPG, van de Veerdonk FL, et al. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. JAMA 2023;329:1183-96.
15. McCarthy MW, Naggie S, Boulware DR, et al. Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. JAMA 2023;329:296-305.
16. Cao Z, Gao W, Bao H, et al. VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. N Engl J Med 2023;388:406-17.
17. Sandhu HK, Booth K, Furlan AD, et al. Reducing Opioid Use for Chronic Pain With a Group-Based Intervention: A Randomized Clinical Trial. JAMA 2023;329:1745-56.
18. Ladapo JA, Orstad SL, Wali S, et al. Effectiveness of Goal-Directed and Outcome-Based Financial Incentives for Weight Loss in Primary Care Patients With Obesity Living in Socioeconomically Disadvantaged Neighborhoods: A Randomized Clinical Trial. JAMA Intern Med 2023;183:61-9.
19. Simbiri KO, Williams CK, Macaluso M, Giordano A. Promoting Cancer Control in Africa With ”Ubuntu”: A Report of the African Organization for Research and Training in Africa (AORTIC) 10th Conference, 2015 in Marrakech, Morocco. J Cell Physiol 2017;232:2287-95.
20. Hu C. A new “single” era of biomedicine and implications in disease research. J Bio-X Res 2023;6:37-48.
21. Schnabel RB, Marinelli EA, Arbelo E, et al. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference. Europace 2023;25:6-27.
22. Baldassarre D, Iacoviello L, Baetta R, et al. CV-PREVITAL Study Group. Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention. BMJ Open 2023;13:e072040.
23. Yu Z, Fidler TP, Ruan Y, et al. Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk. J Clin Invest 2023;133:e168597.
24. Gray MP, Berman Y, Bottà G, et al. PPP-CAD Collaborators. Incorporating a polygenic risk score-triaged coronary calcium score into cardiovascular disease examinations to identify subclinical coronary artery disease (ESCALATE): Protocol for a prospective, nonrandomized implementation trial. Am Heart J 2023;264:163-73.
25. Matsushita K, Kaptoge S, Hageman SHJ, et al. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP. Eur J Prev Cardiol 2023;30:8-16.
26. Mark PB, Carrero JJ, Matsushita K, et al. Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study. Eur Heart J 2023;44:1157-66.
27. Huang Y, Cheung CY, Li D, et al. AI-integrated ocular imaging for predicting cardiovascular disease: advancements and future outlook. Eye (Lond) 2023; Sep 14. doi: 10.1038/s41433-023-02724-4.
28. Yan Z, Zhong L, Zhu W, Chung SK, Hou P. Chinese herbal medicine for the treatment of cardiovascular diseases ─ Targeting cardiac ion channels. Pharmacol Res 2023;192:106765.
29. Li C, Wang C, Hao J, et al. Level of evidence supporting the Chinese cardiovascular disease clinical practice guidelines and its evolution in the past two decades. Lancet Reg Health West Pac 2023;36:100773.
30. Hu C. Emergency Protective Measures and Strategies of Covid-19: From Lifestyle to Traditional Chinese Medicine. Clin Complement Med Pharmacol 2023;3:100089.